FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to novel 2,5-disubstituted tetrahydrofurans or tetrahydrothiophenes of the formula (I): where Ar means phenyl that is optionally substituted with at least one group taken among halide (including but not limiting with fluorine atom), lower alkoxy- (including methoxy-), lower aryloxy- (including phenoxy-group), cyano-group or R3; m = 1; W means independently -AN(OM)C(O)N-(R4)R4, -AN-R3-C(O)N(OM)-R4, -AN(OM)C(O)-R4, AC(O)N(OM)-R4, -C(O)N(OM)-R4 or C(O)NHA where A means lower alkyl, lower alkenyl or lower alkynyl where one or more carbon atoms can be optionally substituted with O, N or S; M means hydrogen atom, pharmaceutically acceptable cation; X means O, S; Y means O, S, hydrogen atom, lower alkyl, lower alkenyl, lower alkynyl, alkaryl; R1 and R2 mean independently hydrogen atom, lower alkyl, halogen atom or COOH; R3 and R4 mean independently hydrogen atom, alkyl, alkenyl, alkynyl, C1-6-alkoxy-C1-C10-alkyl or C1-6-alkylthio-C1-10-alkyl that show an anti-inflammatory activity due to inhibitory effect on activity of 5-lipoxygenase as antagonists of PAF-receptors and show a dual activity, i. e. acting as an antagonist of PAF-receptor and an inhibitor of 5-lipoxygenase. Invention also relates to a pharmaceutical composition based on said compounds and methods of treatment of inflammatory states. EFFECT: improved method of synthesis, valuable medicinal properties. 38 cl, 5 tbl, 5 dwg, 12 ex
Title |
Year |
Author |
Number |
NOVEL NUCLEOSIDES WITH BICYCLIC SUGAR MOIETY AND OLIGONUCLEOTIDES COMPRISING THEREOF |
1999 |
|
RU2211223C2 |
GLUTAMIC ACID DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF GROWTH AND PROLIFERATION OF CELLS |
1994 |
- Varni Majkl D.
- Romajnz Uil'Jam Kh. Iii
- Pamer Sintija L.
|
RU2136686C1 |
MONOCYCLIC L-NUCLEOSIDES, THEIR ANALOGUES AND USING |
1997 |
- Ramasejmi Kandasejmi
- Tehm Robert
- Ehverett Devron
|
RU2188828C2 |
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE |
2009 |
|
RU2514937C2 |
AZACYCLIC COMPOUNDS TO BE USED IN TREATING SEROTONIN-MEDIATED DISEASES |
2001 |
- Anderson Karl M.
- Kroston Glenn
- Khansen E.L.
- Uldam A.K.
|
RU2398765C1 |
2-[4-[2-(2-AMINO-4-OXO-4,6,7,8-TETRAHYDRO-3H-PYRIMIDO-[5,4-B]- -[1,4]-THIAZINE-6-YL)ETHYL]BENZOYL (OR THIENYLCARBONYL)-AMINO]- -PENTANEDIOIC ACID OR ITS LOWER ALKYL ESTER, A METHOD OF INHIBITION AND PROLIFERATION OF CELLS AND A METHOD OF INHIBITION OF AN ENZYME ACTIVITY |
1994 |
- Majkl D.Varni
- Sindija L.Palmer
- Uill'Jam Kh.Romines
|
RU2127275C1 |
RACEMIC AND OPTIC ACTIVE DERIVATIVES OF TETRALIN AND 7-HYDROXYTETRALIN |
1992 |
- Dzhejms Frederik Ehggler[Us]
- Ehntoni Marfet[Us]
- Lorens Sherman Melvin
|
RU2073673C1 |
NEW COMPOUNDS AND COMPOSITIONS FOR CATHEPSIN INHIBITION |
2004 |
- Turajratnam Sukantini
- Oldous Dehvid Dzhon
- Lerua Vensan
- Timm Andreas Pol
|
RU2346943C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES |
2001 |
- Bodkin Majkl
- Ehriksson Tomas
- Khansen Peter
- Khemmerling Martin
- Khenriksson Krister
- Klingstedt Tomas
- Pettersson Lars
|
RU2265011C2 |
ARYL-S(O)N-SUBSTITUTED CARBOXYLIC-HYDROXAMIC ACIDS AND METHOD OF THEIR SYNTHESIS |
1996 |
- Bender Stiven Li
- Broka Kris Allen
- Kehmpbell Dzheffri Allen
- Kastelkhano Arlindo Lukas
- Khendriks Robert Tehn
- Sarma Keshab
- Fisher Lourens Ehmerson
|
RU2175316C2 |